IRIS Accounts Production v24.3.0.553 08721100 Board of Directors 30.10.22 29.10.23 29.10.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh087211002022-10-29087211002023-10-29087211002022-10-302023-10-29087211002021-10-29087211002021-10-302022-10-29087211002022-10-2908721100ns15:EnglandWales2022-10-302023-10-2908721100ns14:PoundSterling2022-10-302023-10-2908721100ns10:Director12022-10-302023-10-2908721100ns10:PrivateLimitedCompanyLtd2022-10-302023-10-2908721100ns10:Micro-entities2022-10-302023-10-2908721100ns10:AuditExempt-NoAccountantsReport2022-10-302023-10-2908721100ns10:FullAccounts2022-10-302023-10-2908721100ns5:CurrentFinancialInstruments2023-10-2908721100ns5:CurrentFinancialInstruments2022-10-2908721100ns5:Non-currentFinancialInstruments2023-10-2908721100ns5:Non-currentFinancialInstruments2022-10-2908721100ns10:RegisteredOffice2022-10-302023-10-29
REGISTERED NUMBER: 08721100 (England and Wales)















Unaudited Financial Statements for the Year Ended 29 October 2023

for

Medspro Ltd

Medspro Ltd (Registered number: 08721100)






Contents of the Financial Statements
for the Year Ended 29 October 2023




Page

Balance Sheet 1


Medspro Ltd (Registered number: 08721100)

Balance Sheet
29 October 2023

29.10.23 29.10.22
£ £ £ £
FIXED ASSETS 144,556 185,414

CURRENT ASSETS 356,278 197,999

CREDITORS
Amounts falling due within one year (155,321 ) (81,491 )
NET CURRENT ASSETS 200,957 116,508
TOTAL ASSETS LESS CURRENT
LIABILITIES

345,513

301,922

CREDITORS
Amounts falling due after more than one
year

81,307

132,290
NET ASSETS 264,206 169,632

CAPITAL AND RESERVES 264,206 169,632

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Medspro Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08721100

Registered office: 20 Steanard Lane
Mirfield
West Yorkshire
WF14 8HB

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2022 - 1 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

he following advances and credits to directors subsisted during the periods ended 29 October 2023 and 29 October 2022:



29.10.2329.10.22
££
Director 1
Balance outstanding at start of year1,4084,781
Amounts advanced95,19144,119
Amounts repaid(45,161)(47,492)
Balance outstanding at end of year51,4381,408
.

Medspro Ltd (Registered number: 08721100)

Balance Sheet - continued
29 October 2023

NOTES TO THE FINANCIAL STATEMENTS

4. OTHER FINANCIAL COMMITMENTS

Within the balance sheet there is a loan due for £13,721 (2022: £18,636), repayable on demand.

Within the balance sheet there are HP commitments totalling £98,526 (2022: £143,653).

5. OFF-BALANCE SHEET ARRANGEMENTS

Within the balance sheet, there are leasing commitments due within a year of £nil (2022 £582).



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 28 November 2024 and were signed on its behalf by:





Dr D M Glover - Director